ESOPHAGEAL SQUAMOUS CELL CANCER
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancers: XB010 trial launches
Disease control Recruiting nowThis early-phase study tests a new drug called XB010, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and check for any side effects. About 396 adults with…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated May 26, 2026 02:25 UTC
-
New drug KIVU-107 targets tough tumors in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug, KIVU-107, in about 76 adults with advanced solid tumors that have not responded to standard treatments. The drug is an antibody-drug conjugate designed to deliver a cancer-killing agent directly to tumor cells. The main goal is to find the…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Kivu Bioscience Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC